Report Overview
This report provides a deep insight into the global Non-Invasive Drug Delivery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-Invasive Drug Delivery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-Invasive Drug Delivery market in any manner.
Global Non-Invasive Drug Delivery Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Adherium Limited
Capsule Technologies, Inc.
Crossject S.A.
Diabeloop SA
HNS International, Inc.
Inovio Pharmaceuticals, Inc.
Medtronic Plc.
Novartis AG
PenJet Corporation
PharmaJet
Portal Instruments
ResMed
Sensiron AG
Tandem Diabetes Care, Inc.
Teva Pharmaceuticals Industries Ltd.
Market Segmentation (by Type)
Artificial Pancreas
Needle Free Injector
Digital Respiratory Devices
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Non-Invasive Drug Delivery Market
? Overview of the regional outlook of the Non-Invasive Drug Delivery Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-Invasive Drug Delivery Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Non-Invasive Drug Delivery
1.2 Key Market Segments
1.2.1 Non-Invasive Drug Delivery Segment by Type
1.2.2 Non-Invasive Drug Delivery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Non-Invasive Drug Delivery Market Overview
2.1 Global Market Overview
2.1.1 Global Non-Invasive Drug Delivery Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Non-Invasive Drug Delivery Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Non-Invasive Drug Delivery Market Competitive Landscape
3.1 Global Non-Invasive Drug Delivery Sales by Manufacturers (2019-2024)
3.2 Global Non-Invasive Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-Invasive Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-Invasive Drug Delivery Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-Invasive Drug Delivery Sales Sites, Area Served, Product Type
3.6 Non-Invasive Drug Delivery Market Competitive Situation and Trends
3.6.1 Non-Invasive Drug Delivery Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-Invasive Drug Delivery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Non-Invasive Drug Delivery Industry Chain Analysis
4.1 Non-Invasive Drug Delivery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Non-Invasive Drug Delivery Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Non-Invasive Drug Delivery Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Invasive Drug Delivery Sales Market Share by Type (2019-2024)
6.3 Global Non-Invasive Drug Delivery Market Size Market Share by Type (2019-2024)
6.4 Global Non-Invasive Drug Delivery Price by Type (2019-2024)
7 Non-Invasive Drug Delivery Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Invasive Drug Delivery Market Sales by Application (2019-2024)
7.3 Global Non-Invasive Drug Delivery Market Size (M USD) by Application (2019-2024)
7.4 Global Non-Invasive Drug Delivery Sales Growth Rate by Application (2019-2024)
8 Non-Invasive Drug Delivery Market Segmentation by Region
8.1 Global Non-Invasive Drug Delivery Sales by Region
8.1.1 Global Non-Invasive Drug Delivery Sales by Region
8.1.2 Global Non-Invasive Drug Delivery Sales Market Share by Region
8.2 North America
8.2.1 North America Non-Invasive Drug Delivery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-Invasive Drug Delivery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-Invasive Drug Delivery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-Invasive Drug Delivery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-Invasive Drug Delivery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Adherium Limited
9.1.1 Adherium Limited Non-Invasive Drug Delivery Basic Information
9.1.2 Adherium Limited Non-Invasive Drug Delivery Product Overview
9.1.3 Adherium Limited Non-Invasive Drug Delivery Product Market Performance
9.1.4 Adherium Limited Business Overview
9.1.5 Adherium Limited Non-Invasive Drug Delivery SWOT Analysis
9.1.6 Adherium Limited Recent Developments
9.2 Capsule Technologies, Inc.
9.2.1 Capsule Technologies, Inc. Non-Invasive Drug Delivery Basic Information
9.2.2 Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Overview
9.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Market Performance
9.2.4 Capsule Technologies, Inc. Business Overview
9.2.5 Capsule Technologies, Inc. Non-Invasive Drug Delivery SWOT Analysis
9.2.6 Capsule Technologies, Inc. Recent Developments
9.3 Crossject S.A.
9.3.1 Crossject S.A. Non-Invasive Drug Delivery Basic Information
9.3.2 Crossject S.A. Non-Invasive Drug Delivery Product Overview
9.3.3 Crossject S.A. Non-Invasive Drug Delivery Product Market Performance
9.3.4 Crossject S.A. Non-Invasive Drug Delivery SWOT Analysis
9.3.5 Crossject S.A. Business Overview
9.3.6 Crossject S.A. Recent Developments
9.4 Diabeloop SA
9.4.1 Diabeloop SA Non-Invasive Drug Delivery Basic Information
9.4.2 Diabeloop SA Non-Invasive Drug Delivery Product Overview
9.4.3 Diabeloop SA Non-Invasive Drug Delivery Product Market Performance
9.4.4 Diabeloop SA Business Overview
9.4.5 Diabeloop SA Recent Developments
9.5 HNS International, Inc.
9.5.1 HNS International, Inc. Non-Invasive Drug Delivery Basic Information
9.5.2 HNS International, Inc. Non-Invasive Drug Delivery Product Overview
9.5.3 HNS International, Inc. Non-Invasive Drug Delivery Product Market Performance
9.5.4 HNS International, Inc. Business Overview
9.5.5 HNS International, Inc. Recent Developments
9.6 Inovio Pharmaceuticals, Inc.
9.6.1 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Basic Information
9.6.2 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Overview
9.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Market Performance
9.6.4 Inovio Pharmaceuticals, Inc. Business Overview
9.6.5 Inovio Pharmaceuticals, Inc. Recent Developments
9.7 Medtronic Plc.
9.7.1 Medtronic Plc. Non-Invasive Drug Delivery Basic Information
9.7.2 Medtronic Plc. Non-Invasive Drug Delivery Product Overview
9.7.3 Medtronic Plc. Non-Invasive Drug Delivery Product Market Performance
9.7.4 Medtronic Plc. Business Overview
9.7.5 Medtronic Plc. Recent Developments
9.8 Novartis AG
9.8.1 Novartis AG Non-Invasive Drug Delivery Basic Information
9.8.2 Novartis AG Non-Invasive Drug Delivery Product Overview
9.8.3 Novartis AG Non-Invasive Drug Delivery Product Market Performance
9.8.4 Novartis AG Business Overview
9.8.5 Novartis AG Recent Developments
9.9 PenJet Corporation
9.9.1 PenJet Corporation Non-Invasive Drug Delivery Basic Information
9.9.2 PenJet Corporation Non-Invasive Drug Delivery Product Overview
9.9.3 PenJet Corporation Non-Invasive Drug Delivery Product Market Performance
9.9.4 PenJet Corporation Business Overview
9.9.5 PenJet Corporation Recent Developments
9.10 PharmaJet
9.10.1 PharmaJet Non-Invasive Drug Delivery Basic Information
9.10.2 PharmaJet Non-Invasive Drug Delivery Product Overview
9.10.3 PharmaJet Non-Invasive Drug Delivery Product Market Performance
9.10.4 PharmaJet Business Overview
9.10.5 PharmaJet Recent Developments
9.11 Portal Instruments
9.11.1 Portal Instruments Non-Invasive Drug Delivery Basic Information
9.11.2 Portal Instruments Non-Invasive Drug Delivery Product Overview
9.11.3 Portal Instruments Non-Invasive Drug Delivery Product Market Performance
9.11.4 Portal Instruments Business Overview
9.11.5 Portal Instruments Recent Developments
9.12 ResMed
9.12.1 ResMed Non-Invasive Drug Delivery Basic Information
9.12.2 ResMed Non-Invasive Drug Delivery Product Overview
9.12.3 ResMed Non-Invasive Drug Delivery Product Market Performance
9.12.4 ResMed Business Overview
9.12.5 ResMed Recent Developments
9.13 Sensiron AG
9.13.1 Sensiron AG Non-Invasive Drug Delivery Basic Information
9.13.2 Sensiron AG Non-Invasive Drug Delivery Product Overview
9.13.3 Sensiron AG Non-Invasive Drug Delivery Product Market Performance
9.13.4 Sensiron AG Business Overview
9.13.5 Sensiron AG Recent Developments
9.14 Tandem Diabetes Care, Inc.
9.14.1 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Basic Information
9.14.2 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Overview
9.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Market Performance
9.14.4 Tandem Diabetes Care, Inc. Business Overview
9.14.5 Tandem Diabetes Care, Inc. Recent Developments
9.15 Teva Pharmaceuticals Industries Ltd.
9.15.1 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Basic Information
9.15.2 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Overview
9.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Market Performance
9.15.4 Teva Pharmaceuticals Industries Ltd. Business Overview
9.15.5 Teva Pharmaceuticals Industries Ltd. Recent Developments
10 Non-Invasive Drug Delivery Market Forecast by Region
10.1 Global Non-Invasive Drug Delivery Market Size Forecast
10.2 Global Non-Invasive Drug Delivery Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-Invasive Drug Delivery Market Size Forecast by Country
10.2.3 Asia Pacific Non-Invasive Drug Delivery Market Size Forecast by Region
10.2.4 South America Non-Invasive Drug Delivery Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non-Invasive Drug Delivery by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Non-Invasive Drug Delivery Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Non-Invasive Drug Delivery by Type (2025-2030)
11.1.2 Global Non-Invasive Drug Delivery Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Non-Invasive Drug Delivery by Type (2025-2030)
11.2 Global Non-Invasive Drug Delivery Market Forecast by Application (2025-2030)
11.2.1 Global Non-Invasive Drug Delivery Sales (K Units) Forecast by Application
11.2.2 Global Non-Invasive Drug Delivery Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-Invasive Drug Delivery Market Size Comparison by Region (M USD)
Table 5. Global Non-Invasive Drug Delivery Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Non-Invasive Drug Delivery Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Non-Invasive Drug Delivery Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Non-Invasive Drug Delivery Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Drug Delivery as of 2022)
Table 10. Global Market Non-Invasive Drug Delivery Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Non-Invasive Drug Delivery Sales Sites and Area Served
Table 12. Manufacturers Non-Invasive Drug Delivery Product Type
Table 13. Global Non-Invasive Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non-Invasive Drug Delivery
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-Invasive Drug Delivery Market Challenges
Table 22. Global Non-Invasive Drug Delivery Sales by Type (K Units)
Table 23. Global Non-Invasive Drug Delivery Market Size by Type (M USD)
Table 24. Global Non-Invasive Drug Delivery Sales (K Units) by Type (2019-2024)
Table 25. Global Non-Invasive Drug Delivery Sales Market Share by Type (2019-2024)
Table 26. Global Non-Invasive Drug Delivery Market Size (M USD) by Type (2019-2024)
Table 27. Global Non-Invasive Drug Delivery Market Size Share by Type (2019-2024)
Table 28. Global Non-Invasive Drug Delivery Price (USD/Unit) by Type (2019-2024)
Table 29. Global Non-Invasive Drug Delivery Sales (K Units) by Application
Table 30. Global Non-Invasive Drug Delivery Market Size by Application
Table 31. Global Non-Invasive Drug Delivery Sales by Application (2019-2024) & (K Units)
Table 32. Global Non-Invasive Drug Delivery Sales Market Share by Application (2019-2024)
Table 33. Global Non-Invasive Drug Delivery Sales by Application (2019-2024) & (M USD)
Table 34. Global Non-Invasive Drug Delivery Market Share by Application (2019-2024)
Table 35. Global Non-Invasive Drug Delivery Sales Growth Rate by Application (2019-2024)
Table 36. Global Non-Invasive Drug Delivery Sales by Region (2019-2024) & (K Units)
Table 37. Global Non-Invasive Drug Delivery Sales Market Share by Region (2019-2024)
Table 38. North America Non-Invasive Drug Delivery Sales by Country (2019-2024) & (K Units)
Table 39. Europe Non-Invasive Drug Delivery Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Non-Invasive Drug Delivery Sales by Region (2019-2024) & (K Units)
Table 41. South America Non-Invasive Drug Delivery Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Non-Invasive Drug Delivery Sales by Region (2019-2024) & (K Units)
Table 43. Adherium Limited Non-Invasive Drug Delivery Basic Information
Table 44. Adherium Limited Non-Invasive Drug Delivery Product Overview
Table 45. Adherium Limited Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Adherium Limited Business Overview
Table 47. Adherium Limited Non-Invasive Drug Delivery SWOT Analysis
Table 48. Adherium Limited Recent Developments
Table 49. Capsule Technologies, Inc. Non-Invasive Drug Delivery Basic Information
Table 50. Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Overview
Table 51. Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Capsule Technologies, Inc. Business Overview
Table 53. Capsule Technologies, Inc. Non-Invasive Drug Delivery SWOT Analysis
Table 54. Capsule Technologies, Inc. Recent Developments
Table 55. Crossject S.A. Non-Invasive Drug Delivery Basic Information
Table 56. Crossject S.A. Non-Invasive Drug Delivery Product Overview
Table 57. Crossject S.A. Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Crossject S.A. Non-Invasive Drug Delivery SWOT Analysis
Table 59. Crossject S.A. Business Overview
Table 60. Crossject S.A. Recent Developments
Table 61. Diabeloop SA Non-Invasive Drug Delivery Basic Information
Table 62. Diabeloop SA Non-Invasive Drug Delivery Product Overview
Table 63. Diabeloop SA Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Diabeloop SA Business Overview
Table 65. Diabeloop SA Recent Developments
Table 66. HNS International, Inc. Non-Invasive Drug Delivery Basic Information
Table 67. HNS International, Inc. Non-Invasive Drug Delivery Product Overview
Table 68. HNS International, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. HNS International, Inc. Business Overview
Table 70. HNS International, Inc. Recent Developments
Table 71. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Basic Information
Table 72. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Overview
Table 73. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Inovio Pharmaceuticals, Inc. Business Overview
Table 75. Inovio Pharmaceuticals, Inc. Recent Developments
Table 76. Medtronic Plc. Non-Invasive Drug Delivery Basic Information
Table 77. Medtronic Plc. Non-Invasive Drug Delivery Product Overview
Table 78. Medtronic Plc. Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Medtronic Plc. Business Overview
Table 80. Medtronic Plc. Recent Developments
Table 81. Novartis AG Non-Invasive Drug Delivery Basic Information
Table 82. Novartis AG Non-Invasive Drug Delivery Product Overview
Table 83. Novartis AG Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Novartis AG Business Overview
Table 85. Novartis AG Recent Developments
Table 86. PenJet Corporation Non-Invasive Drug Delivery Basic Information
Table 87. PenJet Corporation Non-Invasive Drug Delivery Product Overview
Table 88. PenJet Corporation Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. PenJet Corporation Business Overview
Table 90. PenJet Corporation Recent Developments
Table 91. PharmaJet Non-Invasive Drug Delivery Basic Information
Table 92. PharmaJet Non-Invasive Drug Delivery Product Overview
Table 93. PharmaJet Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. PharmaJet Business Overview
Table 95. PharmaJet Recent Developments
Table 96. Portal Instruments Non-Invasive Drug Delivery Basic Information
Table 97. Portal Instruments Non-Invasive Drug Delivery Product Overview
Table 98. Portal Instruments Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Portal Instruments Business Overview
Table 100. Portal Instruments Recent Developments
Table 101. ResMed Non-Invasive Drug Delivery Basic Information
Table 102. ResMed Non-Invasive Drug Delivery Product Overview
Table 103. ResMed Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. ResMed Business Overview
Table 105. ResMed Recent Developments
Table 106. Sensiron AG Non-Invasive Drug Delivery Basic Information
Table 107. Sensiron AG Non-Invasive Drug Delivery Product Overview
Table 108. Sensiron AG Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Sensiron AG Business Overview
Table 110. Sensiron AG Recent Developments
Table 111. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Basic Information
Table 112. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Overview
Table 113. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Tandem Diabetes Care, Inc. Business Overview
Table 115. Tandem Diabetes Care, Inc. Recent Developments
Table 116. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Basic Information
Table 117. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Overview
Table 118. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 120. Teva Pharmaceuticals Industries Ltd. Recent Developments
Table 121. Global Non-Invasive Drug Delivery Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Non-Invasive Drug Delivery Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Non-Invasive Drug Delivery Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Non-Invasive Drug Delivery Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Non-Invasive Drug Delivery Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Non-Invasive Drug Delivery Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Non-Invasive Drug Delivery Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Non-Invasive Drug Delivery Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Non-Invasive Drug Delivery Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Non-Invasive Drug Delivery Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Non-Invasive Drug Delivery Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Non-Invasive Drug Delivery Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Non-Invasive Drug Delivery Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Non-Invasive Drug Delivery Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Non-Invasive Drug Delivery Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Non-Invasive Drug Delivery Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Non-Invasive Drug Delivery Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Non-Invasive Drug Delivery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-Invasive Drug Delivery Market Size (M USD), 2019-2030
Figure 5. Global Non-Invasive Drug Delivery Market Size (M USD) (2019-2030)
Figure 6. Global Non-Invasive Drug Delivery Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-Invasive Drug Delivery Market Size by Country (M USD)
Figure 11. Non-Invasive Drug Delivery Sales Share by Manufacturers in 2023
Figure 12. Global Non-Invasive Drug Delivery Revenue Share by Manufacturers in 2023
Figure 13. Non-Invasive Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non-Invasive Drug Delivery Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non-Invasive Drug Delivery Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non-Invasive Drug Delivery Market Share by Type
Figure 18. Sales Market Share of Non-Invasive Drug Delivery by Type (2019-2024)
Figure 19. Sales Market Share of Non-Invasive Drug Delivery by Type in 2023
Figure 20. Market Size Share of Non-Invasive Drug Delivery by Type (2019-2024)
Figure 21. Market Size Market Share of Non-Invasive Drug Delivery by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-Invasive Drug Delivery Market Share by Application
Figure 24. Global Non-Invasive Drug Delivery Sales Market Share by Application (2019-2024)
Figure 25. Global Non-Invasive Drug Delivery Sales Market Share by Application in 2023
Figure 26. Global Non-Invasive Drug Delivery Market Share by Application (2019-2024)
Figure 27. Global Non-Invasive Drug Delivery Market Share by Application in 2023
Figure 28. Global Non-Invasive Drug Delivery Sales Growth Rate by Application (2019-2024)
Figure 29. Global Non-Invasive Drug Delivery Sales Market Share by Region (2019-2024)
Figure 30. North America Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Non-Invasive Drug Delivery Sales Market Share by Country in 2023
Figure 32. U.S. Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Non-Invasive Drug Delivery Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Non-Invasive Drug Delivery Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Non-Invasive Drug Delivery Sales Market Share by Country in 2023
Figure 37. Germany Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Non-Invasive Drug Delivery Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Non-Invasive Drug Delivery Sales Market Share by Region in 2023
Figure 44. China Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Non-Invasive Drug Delivery Sales and Growth Rate (K Units)
Figure 50. South America Non-Invasive Drug Delivery Sales Market Share by Country in 2023
Figure 51. Brazil Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Non-Invasive Drug Delivery Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Non-Invasive Drug Delivery Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Non-Invasive Drug Delivery Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Non-Invasive Drug Delivery Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Non-Invasive Drug Delivery Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Non-Invasive Drug Delivery Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Non-Invasive Drug Delivery Market Share Forecast by Type (2025-2030)
Figure 65. Global Non-Invasive Drug Delivery Sales Forecast by Application (2025-2030)
Figure 66. Global Non-Invasive Drug Delivery Market Share Forecast by Application (2025-2030)
